We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

32 hedge funds and large institutions have $10.4M invested in OncoSec Medical Incorporated in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

6% less funds holding

Funds holding: 34 → 32 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

45% less capital invested

Capital invested by funds: $18.9M → $10.4M (-$8.52M)

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$32.3K
2
Invesco
Invesco
Georgia
+$17.8K
3
Jane Street
Jane Street
New York
+$14.8K
4
MSAM
Moloney Securities Asset Management
Missouri
+$11.4K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$9.22K

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$4.9M
2
NC
Nexthera Capital
New York
-$1.71M
3
Millennium Management
Millennium Management
New York
-$1.57M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$543K
5
Goldman Sachs
Goldman Sachs
New York
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.74M +$9.22K +30 +0.3%
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$2.56M -$543K -1,768 -18%
NC
3
Nexthera Capital
New York
$1.94M -$1.71M -5,570 -47%
ACA
4
Avoro Capital Advisors
New York
$700K -$4.9M -15,944 -88%
6CM
5
683 Capital Management
New York
$420K – – –
BlackRock
6
BlackRock
New York
$344K +$8.61K +28 +3%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$315K +$32.3K +105 +11%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$215K – – –
DS
9
DRW Securities
Illinois
$210K -$41.5K -135 -17%
Deutsche Bank
10
Deutsche Bank
Germany
$144K +$2.77K +9 +2%
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$134K +$7.68K +25 +6%
Northern Trust
12
Northern Trust
Illinois
$120K – – –
Millennium Management
13
Millennium Management
New York
$98K -$1.57M -5,114 -94%
Zurich Cantonal Bank
14
Zurich Cantonal Bank
Switzerland
$96K – – –
PA
15
Perceptive Advisors
New York
$70K – – –
DADC
16
D.A. Davidson & Co
Montana
$67K +$3.38K +11 +5%
FAAS
17
First Allied Advisory Services
California
$49K – – –
MSAM
18
Moloney Securities Asset Management
Missouri
$32K +$11.4K +37 +54%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$24K – – –
State Street
20
State Street
Massachusetts
$19K – – –
Invesco
21
Invesco
Georgia
$18K +$17.8K +58 New
Jane Street
22
Jane Street
New York
$15K +$14.8K +48 New
Wells Fargo
23
Wells Fargo
California
$11K -$23.1K -75 -67%
Morgan Stanley
24
Morgan Stanley
New York
$9K +$5.84K +19 +190%
PNC Financial Services Group
25
PNC Financial Services Group
Pennsylvania
$8K – – –
1
2

ONCS Hedge Fund Activity: Q3 2018 in Review

32 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2018, worth a combined $10.4M — down 45% from $18.9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ONCS and 4 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Geode Capital Management, adding an estimated $32.3K. The largest seller was Avoro Capital Advisors, cutting an estimated $4.9M.

  • 32 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2018, down from 34 in Q2 2018.
  • Funds reported $10.4M of OncoSec Medical Incorporated stock for Q3 2018, down 45% quarter-over-quarter.
  • 4 funds opened new OncoSec Medical Incorporated positions in Q3 2018 and 6 closed out, a net change of -2 holders.
  • The largest OncoSec Medical Incorporated buyer in Q3 2018 was Geode Capital Management, an estimated $32.3K added.
  • The largest OncoSec Medical Incorporated seller in Q3 2018 was Avoro Capital Advisors, an estimated $4.9M sold.

Based on aggregated 13F filings for Q3 2018.